Large-cap Health Care company Quest Diagnostics has logged a -1.8% change today on a trading volume of 970,851. The average volume for the stock is 941,626.
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. Based in Secaucus, United States the company has 45,000 full time employees and a market cap of $20,817,659,904. Quest Diagnostics currently offers its equity investors a dividend that yields 1.7% per year.
The company is now trading -7.16% away from its average analyst target price of $195.38 per share. The 16 analysts following the stock have set target prices ranging from $166.0 to $215.0, and on average give Quest Diagnostics a rating of buy.
Over the last 52 weeks, DGX stock has risen 17.5%, which amounts to a 1.3% difference compared to the S&P 500. The stock's 52 week high is $197.55 whereas its 52 week low is $148.7 per share. With its net margins declining an average -4.1% over the last 6 years, Quest Diagnostics may not have a strong enough profitability trend to support its stock price.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 9,872,000 | 921,000 | 9 | -10.0 |
| 2023 | 9,252,000 | 908,000 | 10 | 0.0 |
| 2022 | 9,883,000 | 1,015,000 | 10 | -47.37 |
| 2021 | 10,788,000 | 2,080,000 | 19 | 18.75 |
| 2020 | 9,437,000 | 1,499,000 | 16 | 33.33 |
| 2019 | 7,726,000 | 906,000 | 12 |
